重组人干扰素α2b雾化吸入治疗毛细支气管炎疗效观察

Efficacy of recombinant human interferon α 2b nebulization inhalation in the treatment of bronchiolitis

目的:探讨干扰素雾化吸入治疗毛细支气管炎的临床疗效。方法:收治毛细支气管炎患儿80例,分为对照组和治疗组。对照组采用常规治疗,治疗组在对照组基础上加用重组人干扰素雾化吸入,比较两组治疗效果。结果:治疗组的咳嗽、喘憋、肺部哮鸣音消失时间均早于对照组(P<0.01)。结论:干扰素雾化吸入治疗毛细支气管炎的临床疗效显著。

Objective:To explore the efficacy of interferon nebulization inhalation in the treatment of bronchiolitis.Methods:80cases of children with bronchiolitis were selected.They were divided into the control group and the treatment group.The control group was treated with conventional therapy.The treatment group added recombinant human interferon nebulization inhalation on the basis of the control group.We compared the therapeutic effect of two groups.Results:In the treatment group,the coughing,wheezing and pulmonary wheezing disappeared time were earlier than the control group(P<0.01).Conclusion:The efficacy of interferon nebulization inhalation in the treatment of bronchiolitis was significant.